Processa Pharmaceuticals, Inc.
PCSA
$0.2294
-$0.0059-2.51%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -2.73M | -3.38M | -3.01M | -2.73M | -2.40M |
| Total Depreciation and Amortization | 300.00 | 200.00 | 100.00 | 100.00 | 100.00 |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 177.50K | 176.20K | 173.90K | 189.00K | 277.80K |
| Change in Net Operating Assets | 303.20K | -394.30K | -509.60K | 488.30K | 3.10K |
| Cash from Operations | -2.25M | -3.60M | -3.35M | -2.05M | -2.12M |
| Capital Expenditure | 0.00 | -3.20K | -- | -- | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 0.00 | -3.20K | -- | -- | 0.00 |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -1.50K | -1.40K | -1.40K | -900.00 | -- |
| Issuance of Common Stock | 549.40K | 931.30K | 0.00 | 6.28M | -- |
| Repurchase of Common Stock | -300.00 | -3.70K | -2.00K | -18.50K | -30.60K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 547.60K | 926.20K | -3.40K | 6.26M | -30.60K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.70M | -2.68M | -3.35M | 4.21M | -2.15M |